CN100444876C - 一种治疗盆腔炎的药物组合及其制剂 - Google Patents
一种治疗盆腔炎的药物组合及其制剂 Download PDFInfo
- Publication number
- CN100444876C CN100444876C CNB2006100427515A CN200610042751A CN100444876C CN 100444876 C CN100444876 C CN 100444876C CN B2006100427515 A CNB2006100427515 A CN B2006100427515A CN 200610042751 A CN200610042751 A CN 200610042751A CN 100444876 C CN100444876 C CN 100444876C
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- present
- blood
- rat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title abstract description 5
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims description 30
- 229940079593 drug Drugs 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 32
- 229940126678 chinese medicines Drugs 0.000 abstract description 2
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 40
- 239000008280 blood Substances 0.000 description 40
- 230000001684 chronic effect Effects 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 210000004291 uterus Anatomy 0.000 description 14
- 208000007536 Thrombosis Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 230000008595 infiltration Effects 0.000 description 8
- 238000001764 infiltration Methods 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 6
- 210000002808 connective tissue Anatomy 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 230000035755 proliferation Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004568 cement Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000002826 placenta Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000003285 pharmacodynamic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010018691 Granuloma Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 3
- 229960001259 diclofenac Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000003101 oviduct Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 231100000027 toxicology Toxicity 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 208000007106 menorrhagia Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000002110 toxicologic effect Effects 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- -1 hematology Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100427515A CN100444876C (zh) | 2006-04-29 | 2006-04-29 | 一种治疗盆腔炎的药物组合及其制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100427515A CN100444876C (zh) | 2006-04-29 | 2006-04-29 | 一种治疗盆腔炎的药物组合及其制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1879828A CN1879828A (zh) | 2006-12-20 |
CN100444876C true CN100444876C (zh) | 2008-12-24 |
Family
ID=37518329
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100427515A Active CN100444876C (zh) | 2006-04-29 | 2006-04-29 | 一种治疗盆腔炎的药物组合及其制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100444876C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491021A (zh) * | 2014-12-01 | 2015-04-08 | 郭文喜 | 一种治疗慢性盆腔炎的中药组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1730092A (zh) * | 2005-07-08 | 2006-02-08 | 北京润德康医药技术有限公司 | 一种治疗妇科炎症的中药复方制剂及其制备方法 |
-
2006
- 2006-04-29 CN CNB2006100427515A patent/CN100444876C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1730092A (zh) * | 2005-07-08 | 2006-02-08 | 北京润德康医药技术有限公司 | 一种治疗妇科炎症的中药复方制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1879828A (zh) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103623358B (zh) | 一种治疗急、慢性咽炎的中药汤剂 | |
CN102283909B (zh) | 治疗肛肠疾病、肥胖、高脂血症、痤疮的药物及其应用 | |
CN101983644A (zh) | 一种治疗中风后遗症的药剂 | |
CN103446528B (zh) | 一种用于止痛消肿的中药组合物及其制剂 | |
CN101919969B (zh) | 一种治疗痔疮中药口服液制剂 | |
CN104825561B (zh) | 一种治疗关节炎的中药 | |
CN102772650A (zh) | 治疗慢性咽炎的中药组合物及其制备方法 | |
CN100444876C (zh) | 一种治疗盆腔炎的药物组合及其制剂 | |
CN102764360B (zh) | 一种治疗急性膀胱炎的中药组合物 | |
CN102166272B (zh) | 一种治疗痔疮的药物及其制备方法 | |
CN104147209B (zh) | 一种治疗慢性盆腔炎的药物及其应用 | |
CN105770847A (zh) | 一种缓解或治疗关节肿痛的中药组合物及制备方法和用途 | |
CN104189477A (zh) | 一种治疗脚气的中药配方 | |
CN103623287B (zh) | 一种治疗阴道炎以及宫颈糜烂的中药洗剂及其制备方法 | |
CN108524697A (zh) | 一种治疗前列腺炎和增生的药物 | |
CN101209276B (zh) | 一种七叶金祛风散瘀活络药酒 | |
CN107456551A (zh) | 一种治疗胃炎的中药 | |
CN103169897A (zh) | 治疗慢性盆腔炎的中药组合物及其用途 | |
CN101474328A (zh) | 一种治疗子宫炎症的中药组合物 | |
CN101288760B (zh) | 一种治疗阑尾炎的外用药 | |
CN104840530A (zh) | 一种痔疮膏及其制备方法 | |
CN104288696A (zh) | 一种治疗痔疮的中药及其制备方法 | |
CN105535209A (zh) | 一种治疗痔疮外洗中药组合物 | |
CN104825808A (zh) | 一种治疗慢性咽炎的中药组合物及其制备方法 | |
CN104771545A (zh) | 一种普外科治疗痔疮的中药配方 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070302 Address after: Shaanxi Weiyang road Xianyang City, China Mansion Applicant after: XI AN TIANJIAN Research Institute OF MED Address before: Building 4, Xi'an hi tech hospital, 16 hi tech Industrial Development Zone, Shaanxi, Xi'an Applicant before: XI AN TIANJIAN MEDICAL SCIENCE |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20160107 Granted publication date: 20081224 Pledgee: Xianyang financing Company Limited by Guarantee Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2015990001209 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20160729 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2015990001209 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20160729 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2016990000644 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PM01 | Change of the registration of the contract for pledge of patent right |
Change date: 20160729 Registration number: 2015990001209 Pledgee after: Xianyang financing guarantee Limited by Share Ltd. Pledgee before: Xianyang financing Company Limited by Guarantee |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20161215 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2016990000644 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20161223 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2016990001162 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20171221 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: Wang Jie|XI AN TIANJIAN Research Institute OF MED Registration number: 2016990001162 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20171229 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: 2017610000182 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190202 Granted publication date: 20081224 Pledgee: Xianyang financing guarantee Limited by Share Ltd. Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: 2017610000182 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20190202 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: 2019990000112 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191209 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: 2019990000112 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicinal composition for treating pelvic inflammation and preparation thereof Effective date of registration: 20191209 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2019990000681 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201224 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2019990000681 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medicine combination and preparation for treating pelvic inflammatory disease Effective date of registration: 20201224 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2020990001493 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220221 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2020990001493 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a drug combination for treating pelvic inflammation and a preparation thereof Effective date of registration: 20220303 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2022610000070 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: Block 7, Area A, Tianhaixing Digital Workshop, north of Hongguang Avenue, North of Hongguang Avenue, Xixian New District, Xixian New District, Shaanxi Province, 710075 Patentee after: Shaanxi Sanzheng Pharmaceutical Co., Ltd. Address before: 712000 Xianyang City, Shaanxi province Weiyang road China Mansion Patentee before: XI AN TIANJIAN Research Institute OF MED |
|
CP03 | Change of name, title or address | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231221 Granted publication date: 20081224 Pledgee: Xi'an innovation financing Company limited by guarantee Pledgor: XI AN TIANJIAN Research Institute OF MED Registration number: Y2022610000070 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |